{"name":"Oncotelic Inc.","slug":"oncotelic-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":70000,"revenueGrowth":-96,"grossMargin":0,"rdSpend":61143,"netIncome":-4523932,"cash":170405,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-08","type":"pipeline","source":"The Manila Times","summary":"Oncotelic Therapeutics Inc. (OTCQB: OTLC) Operates at Intersection of Life Sciences, Advanced Digital Technologies, - The Manila Times","headline":"Oncotelic Therapeutics Inc. (OTCQB: OTLC) Operates at Intersection of Life Sciences, Advanced Digital Technologies,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxQRnh6ZHZaTE5BQTBJOFIzRExCd1NnR3l6Ty14LTBHOFlOdWp4bDcxaHBjYWVlR2cxSUNuSnozVWZRNGpXLU1JNS14Q2UtTXgyWFZVTHpGUjhJbS1qUl9mRHNUMEdfbkhYUkQ4YURublBsbzJXa3FkVEZkUEFrUm1JT2NEck40eWR1REl4bTd0aGt2NWRKRzYwajN5ZnhEWHROV3pjTU0wVnVfV2NweldZU1VTbXBROUVaZXQ0S2lxdWc2SDZwRnlFT1Q2QjFLdEFBVWRTSHNWZ1pOcVJvTzVKN2k5Q2RuOFo0TVdkNHROcTczYk1GeGIxUQ?oc=5","date":"2026-04-07","type":"regulatory","source":"The Globe and Mail","summary":"AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards - The Globe and Mail","headline":"AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQYnVoaWpCWGxKUk00c3B2QlVKV0ZHQWFNd1ZSQl9zRUNTU2lXZ3VwbU9jd0dDaHFvb2NGa2Vpa2lfNXVZNEU0aDNWaGMtblpzQXF3bXpTdDN0dy1EZkpLR3laazA1czVYdHFmWHlzbkpYMzR5aS04ZjNsOVZCMUYxYVlzS0NyUGx0cnZzWkhuVG5rODlUQ292YnVTamFnY0M0TWRaY3Y2dXJVWURaTjhlMnBld016aU5GelZOUHlwcDh1cE5VcVE?oc=5","date":"2026-04-06","type":"deal","source":"TipRanks","summary":"NightFood’s TechForce Robotics Partners with Oncotelic for Pharma Automation - TipRanks","headline":"NightFood’s TechForce Robotics Partners with Oncotelic for Pharma Automation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQdlJkNnBQREsya2JKNlkzTFdYcEZZR25QcUFvdDZhV0k5dTV0WlRSMFN0MnBlaTVZNEI4UV8zd0dVY2JFdEtWM0d4UHZGdjdJMlJIQU5taHk2REpHajNKYTlpUXJMa3NGLWVITjRzNW5oamVER0FTakZBaFF1RlN5NjBwenJEajVyaC0wM2hPbFFSNjh0U0wwVkltMTlsWUI3VXo0MU5XczdETmtaYmwyZEY0V2I5Zk51MWZGUllXbVd0SEFPaGxPQ05hdjFwdE5PX3Q5SWpreEQ1VXNxM2tKbDlrX2tEU1NlSjFLSzhUSDl1MUF1R2Rlbk5vOE5aQlJiU3JSVk51YzRrSGctd1hrX1o0TFlNMWc0ZjQxZQ?oc=5","date":"2026-04-06","type":"deal","source":"Minichart","summary":"Nightfood Holdings (TechForce Robotics) and Oncotelic Therapeutics Announce Strategic AI-Enhanced Robotics Partnership for Pharmaceutical Manufacturing 1 - Minichart","headline":"Nightfood Holdings (TechForce Robotics) and Oncotelic Therapeutics Announce Strategic AI-Enhanced Robotics Partnership f","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxOS1RPWnNITU9BNTRGNFoydXY3NFRaa2hUZGEwSnVqSGZrZDhoRktJazFwLUtpQk9aQ3E1c3AtM3JmVUJLT3p1QnpndU1IVExUdEtkMEtUamE2YXpCMHJFOFU0VXY0d0FHOEd1X0tOM2RZZjNwaXhmbF9fNXFKTDFxN1dqWXU1V201VDdqeU5KNllkcmJOeTVTRXZLY2lVMWtaUDZwa1VydW1MZms2QUhCcmRLWGgtUEtxcHNnQkhOTTNBckZoMzlna0VubVZBY0VWeU11bUtFUG15R1ZWQXZzMko0SUlYdw?oc=5","date":"2026-04-02","type":"deal","source":"TradingView","summary":"Oncotelic Strikes Joint Development and Licensing Deal With TechForce for AI-GMP Robotics - TradingView","headline":"Oncotelic Strikes Joint Development and Licensing Deal With TechForce for AI-GMP Robotics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxPdmhZWDRERlliTE1YOTZLRm8xVjBOZlhmMzI2Y0x2Yl9sWWpUckdBOUZjellqc08yVTdlcWdBYXNqakM4LWZrazdLaVBFVFJiU256cXdQSHltb2pyLVR0TF9hR2ZTcnlWY2d3WEw0eFlRa19Ya1NaZlVMYnMxd0dhS0JycXJybURvRnJGVnhYRm9UcDlwc25SUEt1U0V4U1lTQmxBb3JnRlA3WWxNaEE3YkRsMUhpbzZkVHFZdU0teXNhNlBqelRCd1R2SWJFZGpwZ2I0NDgxalZYZElZcFZOU1lSN3hKT2VsUW9IZk92aEJIM2NVLUY3RzZBZUktTEZsVFdpU1QzR0w3RXRoU2w5T3cwNi12UDhlcENhR3k1VXljSWw0ZDBpOXF2ZHd6U0RpS2hkVGtwaUZrbjhra25Ucg?oc=5","date":"2026-04-02","type":"deal","source":"The Globe and Mail","summary":"Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform - The Globe and Mail","headline":"Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robo","sentiment":"neutral"},{"date":"2026-04-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-03-30","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxQNnFQWnE2aFlNemhiSWNpcWo5Y2ZYV3NKWVVEbGRoNXo5ZmFyY05UanRUV1JoUlp6emJ5bGNacXBKbGI3Ri1ab1g4NnNtdGRlTG5XelNueEZKVFhMODFnWkx3VDVYTGEyQ09aZ0dOdnBMZHFaV0xHaURGUUNJaUdzdWxOM1hBSzNpOFY0b2piT21nZGJYSlIwRWVVM0pRUlNxRjNkT05CVThXaEhFcjhtcU5FYzZCZzNkZ3VaMlRySmNMOHVKeEY0RGtaTDd6TjZqWWc?oc=5","date":"2026-02-19","type":"pipeline","source":"Investing News Network","summary":"Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development - Investing News Network","headline":"Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development","sentiment":"neutral"},{"date":"2026-01-29","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-07","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":70000,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":70000,"period":"2023-12-31"},{"value":1740855,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":61143,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-4523932,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":170405,"cashHistory":[],"totalAssets":26677426,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}